Diarylquinolines target subunit c of mycobacterial ATP synthase
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The diarylquinoline R207910 (TMC207) is a promising candidate in clinical development for the treatment of tuberculosis. Though R207910-resistant mycobacteria bear mutations in ATP synthase, the compound's precise target is not known. Here we establish by genetic, biochemical and binding assays that the oligomeric subunit c (AtpE) of ATP synthase is the target of R207910. Thus targeting energy metabolism is a new, promising approach for antibacterial drug discovery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most promising compounds clinically, the diarylquinolines, have been shown to target the F1Fo-ATP synthase and inhibit ATP synthesis (109, 111, 112).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [111]
Citations
Cites
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,947
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Self-citationMolecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472
Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320
de Jonge, M. R., Koymans, L. H. M., Guillemont, J. E. G., Koul, A., & Andries, K. (2007) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21376 · Cited by 124
Self-citationThe F 1 F o -ATP Synthase of Mycobacterium smegmatis Is Essential for Growth
Tran, S. L., & Cook, G. M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.14.5023-5028.2005 · Cited by 116
Ji, B., Lefrançois, S., Robert, J., Chauffour, A., Truffot-Pernot, C., & Jarlier, V. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00052-06 · Cited by 107
Wang, R., Prince, J. T., & Marcotte, E. M. (2005) · Genome Research · doi:10.1101/gr.3994105 · Cited by 86
Junge, W., & Nelson, N. (2005) · Science · doi:10.1126/science.1112617 · Cited by 60
Cited by
Items 401–500 of 571
Li, X., Luo, X., Wang, B., Fu, L., Chen, X., & Lu, Y. (2025) · mSphere · doi:10.1128/msphere.00149-25 · Cited by 6
Novel heterocycles as antitubercular drugs: A review
Kabir, E., Alam, M., & Haque, M. I. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116978 · Cited by 6
Discovery of Anti‐tubercular Analogues of Bedaquiline with Modified A‐, B‐ and C‐Ring Subunits
Barbaro, L., Nagalingam, G., Triccas, J. A., Tan, L., West, N. P., Priebbenow, D. L., & Baell, J. B. (2022) · ChemMedChem · doi:10.1002/cmdc.202200533 · Cited by 6
Khan, Z., Ualiyeva, D., Jamal, K., Ali, B., Ahmad, F., Sapkota, S., Amissah, O. B., & Bate, P. N. N. (2023) · Medicine in Omics · doi:10.1016/j.meomic.2023.100022 · Cited by 6
Nitschke, J., Huber, R., Vossio, S., Moreau, D., Marcourt, L., Gindro, K., Queiroz, E. F., Soldati, T., & Hanna, N. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1439814 · Cited by 6
Zimenkov, D. V., Ushtanit, A. I., Игоревна, Г. Е., Петровна, Г. Е., Schwartz, Y. S., & Stavitskaya, N. (2025) · Emerging infectious diseases · doi:10.3201/eid3103.241488 · Cited by 6
Carreto-Binaghi, L. E., González, Y., & Guzmán‐Beltrán, S. (2021) · NCT Neumología y Cirugía de Tórax · doi:10.35366/100997 · Cited by 8
Keutzer, L., Salehabad, Y. A., Forsman, L. D., & Simonsson, U. S. H. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12768 · Cited by 6
Araki, M., Hoshi, K., Fujiwara, M., Sasaki, Y., Yonezawa, H., Senpuku, H., Iwamoto-Kihara, A., & Maeda, M. (2013) · Journal of Bacteriology · doi:10.1128/jb.00542-13 · Cited by 6
Antituberculosis agents: Beyond medicinal chemistry rules
Pieroni, M. (2019) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2019.06.001 · Cited by 6
Chatterjee, A., Pandey, S., Dhamija, E., Jaiswal, S., Yabaji, S. M., & Srivastava, K. K. (2019) · Biochimie · doi:10.1016/j.biochi.2019.07.023 · Cited by 6
Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis
Margaryan, H., Evangelopoulos, D., Wildner, L. M., & McHugh, T. D. (2022) · Microorganisms · doi:10.3390/microorganisms10030514 · Cited by 6
Alghamdi, S. A., Qusty, N. F., Maulana, A., Ajmal, M., Khan, M., Mahato, A. K., Verma, S., & Asif, M. (2025) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162023603257 · Cited by 5
Remission spectroscopy resolves the mechanism of action of bedaquiline within living mycobacteria
Harrison, S. H., Walters, R. C., Cheung, C., Springett, R., Cook, G. M., Osman, M. M., & Blaza, J. N. (2025) · Nature Communications · doi:10.1038/s41467-025-65928-0 · Cited by 6
ATP Synthase: Structure, Function and Regulation of a Complex Machine
Bald, D. (2011) · Springer eBooks · doi:10.1007/978-94-007-0388-9_10 · Cited by 6
Self-citationSpectroscopic techniques for elucidating the mechanism of action of antibacterial agents
Bedair, H. M., Hamed, M., Magdy, G., & Mansour, F. R. (2024) · Applied Spectroscopy Reviews · doi:10.1080/05704928.2024.2327519 · Cited by 5
Structural and mechanistic study of a novel inhibitor analogue of M. tuberculosis cytochrome bc1:aa3
Verma, A. K., Kim, R. Q., Lamprecht, D. A., Aguilar-Pérez, C., Wong, S., Véziris, N., Aubry, A., Bartolomé-Nebreda, J. M., Carbajo, R. J., Wetzel, J., et al. (2025) · npj Drug Discovery. · doi:10.1038/s44386-025-00008-3 · Cited by 6
Kehinde, A. O., & Akintola, A. (2012) · African Journal of Biomedical Research · Cited by 5
Medicinal Plants in Targeting Tuberculosis II
Koirala, N., Modi, B., Subba, R. K., Panthi, M., & Xiao, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6850-7_8 · Cited by 5
Prospects for TB Therapeutics Targeting Mycobacterium tuberculosis Phosphosignaling Networks
Av‐Gay, Y., & Alber, T. (2011) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633470.ch11 · Cited by 5
Alajlani, M. M. (2022) · Molecules · doi:10.3390/molecules27030753 · Cited by 5
Gouws, A. C., Kruger, H. G., Gheysens, O. S., Zeevaart, J. R., Govender, T., Naicker, T., & Ebenhan, T. (2022) · Angewandte Chemie · doi:10.1002/ange.202204955 · Cited by 4
D’Oliveira, K. A., Souza, I. D. O., Glanzmann, N., Silva, A. D. D., Bruziguini, C. E. T., Ribeiro, M. A., Canales, C. S. C., Roque‐Borda, C. A., Pavan, F. R., & Cuin, A. (2025) · Journal of Coordination Chemistry · doi:10.1080/00958972.2024.2448518 · Cited by 4
Kavanagh, M. E., McLean, K. J., Gilbert, S. H., Amadi, C. N., Snee, M., Tunnicliffe, R. B., Arora, K., Boshoff, H. I., Fanourakis, A., Rebollo-López, M. J., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00478 · Cited by 4
Meloun, M., Cyrmonová, D., Javůrek, M., & Pekárek, T. (2021) · Journal of Solution Chemistry · doi:10.1007/s10953-021-01055-w · Cited by 4
Dose-ranging activity of the newly registered antituberculosis drug bedaquiline (TMC207)
Grosset, J. H. E., & Ammerman, N. C. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.811848 · Cited by 4
Saini, R., & Dharavath, N. (2018) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-018-1410-3 · Cited by 4
Lapashina, A. S., Shugaeva, T. E., Berezina, K. M., Kholina, T. D., & Feniouk, B. A. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919040084 · Cited by 5
Targeting Molecular and Cellular Mechanisms in Tuberculosis
Singh, L., Dua, K., Kumar, S., Kumar, D., & Majhi, S. (2021) · Springer eBooks · doi:10.1007/978-981-33-6827-9_14 · Cited by 4
Regulatory Mechanisms and Environmental Adaptation of the F-ATPase Family
Iwamoto-Kihara, A. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00419 · Cited by 4
Roy, A., Naik, D., Sau, S., Agnivesh, P. K., Parida, K. K., & Kalia, N. P. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c01066 · Cited by 3
Mosallam, N., O’Neill, P. M., Lisauskaitė, M., Woodley, C. M., Ardrey, A., Jeffreys, L. N., Memelis, I., Almeida, D. V., Lee, J., Converse, P. J., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03274 · Cited by 3
Self-citationA breakthrough in the treatment of multidrug-resistant tuberculosis: A novel and effective approach
Pardeshi, V., Lokhande, T. N., Shelke, A. V., Tuse, T., Pawar, B., & Bonde, C. G. (2022) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ecdt.ecdt_24_22 · Cited by 3
Chen, S., Shang, Y., Zheng, J., Huo, F., Xue, Y., Zhao, L., Jiang, G., Chu, N., & Huang, H. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae405 · Cited by 3
Hit movie reveals how a tuberculosis drug halts ATP synthesis
Mizrahi, V., & Barry, C. E. (2020) · Nature · doi:10.1038/d41586-020-03406-x · Cited by 3
Fekadu, G., Yao, J., & You, J. H. S. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1925111 · Cited by 3
Guo, K., Wang, Y., & Ma, C. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115658 · Cited by 3
Respiration and Oxidative Phosphorylation in Mycobacteria
Berney, M., & Cook, G. M. (2014) · Advances in photosynthesis and respiration · doi:10.1007/978-94-017-8742-0_15 · Cited by 4
Elliott, R. (2011) · Topics in medicinal chemistry · doi:10.1007/978-3-642-23487-3 · Cited by 3
Guillemont, J., Meyer, C., Koul, A., & Andries, K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-08-095167-6.00107-5 · Cited by 3
Self-citationOmel'kov, A. V., Fedorov, V. E., & Степанов, А. А. (2019) · Russian Chemical Bulletin · doi:10.1007/s11172-019-2646-5 · Cited by 3
Sinha, R., & Rahul, R. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_3 · Cited by 4
Campen, R. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17009687.v1 · Cited by 4
Maeda, M. (2010) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.130.191 · Cited by 3
Arshad, K., Salim, J., Talat, M. A., Ashraf, A., & Kanwal, N. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312860 · Cited by 2
Jadhav, K., Gautam, S., Singh, A. K., Verma, R. K., & Yadav, A. B. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107173 · Cited by 3
Verapamil Suppresses the Development of Resistance Against Anti-Tuberculosis Drugs in Mycobacteria
Liu, K., Buitenhek, E., Kuijl, C. P., Mulla, Y., Luirink, J., & Bald, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211124 · Cited by 3
Self-citationMycobacterial Endocarditis, A Rare Form of Infective Endocarditis
Dawi, J., Affa, S., Chorbajian, A., Misakyan, Y., Mohan, A. S., Norris, B. M., Ochsner, J., Yoon, S., & Venketaraman, V. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436182.41 · Cited by 2
Discovery and development of new antibacterial drugs
Elassal, E. S., Fahmy, A., Saad, A. N. M., Ali, A. H., Elshenety, A. H., Badr, O. A., Amer, A. N., Fouda, W. M., & Elshaier, Y. A. M. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18866-4.00012-2 · Cited by 2
ProAD – A database of rotary ion-translocating ATPases in prokaryotic genomes
Litvin, A. V., Lapashina, A. S., Ermidis, A.-P., Gelfand, M. S., & Feniouk, B. A. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1471556 · Cited by 3
Bundutidi, G. M., Mochizuki, K., Matsuo, Y., Hayashishita, M., Sakura, T., Ando, Y., Cook, G. M., Acharjee, R., Bringaud, F., Boshart, M., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07611-0 · Cited by 2
Bédaquiline : de l’in vitro aux essais cliniques d’un nouvel antituberculeux
Guglielmetti, L., & Robert, J. (2015) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2014.12.003 · Cited by 3
Strategies for Tackling Drug Resistance in Tuberculosis
Maveyraud, L. (2017) · Springer eBooks · doi:10.1007/978-981-10-5187-6_7 · Cited by 2
Challenges and Advances in TB Drug Discovery
Khare, G., Nangpal, P., & Tyagi, A. K. (2019) · Springer eBooks · doi:10.1007/978-981-32-9413-4_25 · Cited by 2
Jain, S., Sharma, S., & Sen, D. J. (2022) · Anti-Infective Agents · doi:10.2174/2211352520666220414094155 · Cited by 3
Wang, M.-G., Wu, S., & He, J.-Q. (2021) · Research Square · doi:10.21203/rs.3.rs-472215/v1 · Cited by 2
Identification of Anti-tubercular Compounds in Marine Organisms from Aotearoa
Dasyam, N. (2014) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17008141 · Cited by 2
A Miracle Drug for Tuberculosis: Bedaquiline
Kandasamy, R., & Venkataramanan, S. (2021) · Pondicherry Journal of Nursing · doi:10.5005/jp-journals-10084-12174 · Cited by 1
Roy, A., Banerjee, P., Paul, I., Ghosh, R., & Ray, S. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2441426 · Cited by 1
In vitro and in vivo activity profiles of broad-spectrum bacterial ATP synthase inhibitors
Chamberland, S., Larose, A., Millette, G., Langlois, J.-P., Côté-Gravel, J., Brouillette, É., Droppa‐Almeida, D., Binette, R., Delbrouck, J. A., Diachenko, I., et al. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118493 · Cited by 2
Current and emerging therapies for pulmonary tuberculosis in adults
Mahmood, A., Ashfaq, M. B., Drain, C., Melby, E., Hunter, M., & Shaw, T. D. (2026) · BMJ Medicine · doi:10.1136/bmjmed-2025-001836 · Cited by 1
Scope and Perspectives of New TB Drugs and Vaccines
Meena, J., & Meena, L. S. (2015) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2015.63.73 · Cited by 1
Les nouveaux antituberculeux (2) : nouvelles molécules
Véziris, N. (2013) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2013.06.001 · Cited by 1
Haagsma, A. C., Lu, P., Lill, H., & Bald, D. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.06.049 · Cited by 1
Self-citationBedaquiline: A Promising new agent for the treatment of MDR-TB
Benni, J. M. (2013) · International Journal of Drug Development and Research · Cited by 1
The challenge of new drug discovery for
Arnoult, É., Lounis, N., Guillemont, J., & Andries, K. (2011) · Cited by 1
Self-citationImplications of Chromosomal Mutations for Mycobacterial Drug Resistance
Louw, G., & Sampson, S. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_10 · Cited by 1
An overview of tuberculosis chemotherapy – a literature review
Sarangi, M. K., & Padhi, S. K. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Tuberculosis: Still a Way to go ahead for a Lead- A Review
Bose, P., Harit, A. K., & Halder, K. K. (2017) · Journal of Analytical & Pharmaceutical Research · doi:10.15406/japlr.2017.05.00161 · Cited by 1
Jeon, A. B., Basaraba, R. J., Borlee, B., Gustafson, D., Jackson, M., Melander, C., & Obregón-Henao, A. (2017) · Digital Collections of Colorado (Colorado State University) · doi:10.25675/3.020311 · Cited by 1
Guillemont, J., Lounis, N., & Andries, K. (2016) · doi:10.4155/fseb2013.14.212 · Cited by 1
Self-citationSowmya, Manohar, V. R., Rai, M., Gopalakrishna, H. N., Shetty, R., & Udyavar, S. (2021) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/j.ijpp.2020.039 · Cited by 1
Antituberculosis Drug Repurposing: A New Hope for Tackling Multi-Challenging TB in Timely Manner
Majeed, S., Mehraj, S., & Ahmad, Z. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101642 · Cited by 2
Study of Structurally Diverse Currently Used and Recently Developed Antimycobacterial Drugs
Almehmadi, M. M., Abdulaziz, O., Halawi, M., & Asif, M. (2023) · Medicinal Chemistry · doi:10.2174/1573406419666230111111153 · Cited by 4
Nesci, S. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.01.006 · Cited by 1
Alam, M., Fatima, Z., & Nandi, S. (2023) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666230619094409 · Cited by 1
Uradi, S. (2023) · International Journal of Scientific Reports · doi:10.18203/issn.2454-2156.intjscirep20232515 · Cited by 1
Treatment Strategies for Mycobacterium tuberculosis Infection
Cobongela, S. Z. Z., & Mgwenya, T. N. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007538 · Cited by 1
Population pharmacokinetics of bedaquiline: a systematic review
Jin, J., Cao, J., Zhang, R., Zheng, L., Cai, X., & Li, J. (2025) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-024-03788-1 · Cited by 1
Farid, M. N., Madury, S. A., Muslim, A. S., & ‘Aini, Z. Q. (2025) · Jurnal Kimia Riset · doi:10.20473/jkr.v10i1.69932 · Cited by 1
Alghamdi, S. A., & Asif, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95538 · Cited by 1
Determination of Bioenergetic Parameters in Mycobacterium ulcerans
Thomas, S. S., & Pethe, K. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1779-3_21 · Cited by 1
Respiratory ATP synthesis as drug target for combating tuberculosis
Haagsma, A. C. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1
Li, Z. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.130530955 · Cited by 1
From Empirical Discovery to Targeted Therapy: The Evolution of Tuberculosis TreatmentPreprint
Waller, N. J. E., & Rhee, K. Y. (2026) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041821 · Cited by 1
Miller, C. H. (2013) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17004946.v1
Hctor, R. (2012) · InTech eBooks · doi:10.5772/30422
Drug-resistance in M. tuberculosis & the characterisation of a new anti-tuberculosis drug-candidate
Huitric, E. (2009) · Figshare
TMC207 for treatment of people with pulmonary tuberculosis
Rosa, B. R., Rolla, V. C., da Cunha, A. J. A., de Paulo, R. F., Medronho, R. D. A., & Atallah, Á. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010082
RetractedRen, J., Jiang, H.-F., Zhao, J., Xin, W., Xu, Y., Chen, X., & Hu, K. (2013) · Cell Biology International · doi:10.1002/cbin.10209
Medications for Extensively Drug-Resistant Tuberculosis: Back to the Future?
Ashby, C. R., Jodlowski, T. Z., & Sym, D. (2008) · Journal of Pharmacy Technology · doi:10.1177/875512250802400205
Nouvelles cibles bactériennes pour les mycobactéries
Sougakoff, W. (2009) · Antibiotiques · doi:10.1016/j.antib.2009.01.003
Elucidation of the mode of action of a furanone based antituberculosis compound
Ngwane, A. H. (2012) · SUNScholar (Stellenbosch University)
Zhu, L., He, C.-S., Liu, Y.-M., Yuan, Q., Chen, J., Zhu, Q., Zhang, Q., & Zhang, H. (2015) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2015.7359827
Bedaquiline: A Novel Addition to Anti-Tubercular Armamentarium
Nandha, R. (2013) · Journal of Biomedical and Pharmaceutical Research · Cited by 1
Pharmacometric Models to Improve Treatment of Tuberculosis
Svensson, E. M. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Mechanisms of Action of Antibacterial Agents
Buensalido, J. A. L., DeMarco, C. E., & Lerner, S. (2015) · CRC Press eBooks · doi:10.1201/b17871-13
Design, Synthesis of Diaryl Quinoline Compounds With Anti-TuberculosisActivity Research
Wang, G. (2016) · Research and reviews : journal of pharmacology and toxicological studies
Metadata
- Authors
- Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., Bald, D., & Andries, K.
- Affiliations
- Johnson & Johnson (United States) (US)
- Vrije Universiteit Amsterdam (NL)
- Johnson & Johnson (France) (FR)
- Corresponding author
- Koul, Anil
- Venue
- Nature Chemical Biology
- Published
- 2007-05-13
- Volume
- 3
- Issue
- 6
- Pages
- 323-324
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2093364655
- Cited by
- 547
- References
- 11
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 27 · 2023: 27 · 2022: 40 · 2021: 50 · 2020: 31 · 2019: 40 · 2018: 36 · 2017: 40 · 2016: 23 · 2015: 33 · 2014: 26 · 2013: 31 · 2012: 22
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- diarylquinolines, bedaquiline, subunit c, atpE, tuberculosis, drug target identification, drug resistance, energy metabolism, antibiotic discovery
- MeSH terms
- Antitubercular Agents, Bacterial Proteins, Binding Sites, Kinetics, Quinolines, Electrophoresis, Gel, Two-Dimensional, Mycobacterium smegmatis, Protein Subunits, ATP Synthetase Complexes, Bacterial Proton-Translocating ATPases, Diarylquinolines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.